Cambridge Capital Group
VC Fund
Cambridge, United Kingdom
Cambridge Capital Group (CCG) is a leading business angel group of 70+ investors who have been investing in hi-tech businesses for more than a decade. CCG was formed in the Autumn of 2000 and has been backing tech start-ups in the region ever since. Their members have invested several millions of pounds into more than 30 live portfolio companies inthe Cambridge technology cluster. Membership is an application process, normally following introductions by existing members.Their partner networks are Anglia Capital Group and CCG International, both of which benefit from deal flow developed in Cambridge, Europe's leading hi-tech cluster.
- Total investments:
- 43
- Last investment:
- Lead investor:
- 9%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Cambridge Capital Group invests in
Stages Cambridge Capital Group invests in
Countries Cambridge Capital Group invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $548k–$1.9M
- Series A
- $1.3M–$9.5M
Investment Focus
Industry
- Software 10 (23%)
- Biotechnology 8 (19%)
- Artificial Intelligence 5 (12%)
- Health Care 4 (9%)
- Hardware 3 (7%)
Stage
- Seed 10 (23%)
- Series A 9 (21%)
- Funding Round 7 (16%)
- Series B 4 (9%)
- Series C 3 (7%)
Country
- United Kingdom 27 (63%)
- United States 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Jayne Parker
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Struan McDougall
Founder & Chairman
|
Founder & Chairman | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Semarion
|
Semarion is a spin-out company from the Cavendish Laboratory at the University of Cambridge, operating at the edge of the physical and life sciences. Semarion combines microchip industry materials and techniques engineering and cell biology to tackle unmet drug screening needs. | $3.8M / Venture - Series Unknown / Mar 31, 2026 | |
Cambridge GaN Devices
|
Cambridge GaN Devices develops transistors designed to bring widespread adoption of GaN technology in consumer electronics. | $32M / Series C / Feb 18, 2025 | |
Spotta
|
Spotta is a provider of smart pest systems. Spotta commercialized Bed Pod, its first product which monitors bed bugs in hotels and other multi-room accommodation offerings. | $3.8M / Series A / Dec 15, 2023 | |
Cytochroma
|
Cytochroma manufacture genetically diverse stem cell-derived models to predict the safety and effect of drugs in a global population. Cytochroma’s automated cell manufacture, physiologically relevant models and rapid screening platform makes preclinical testing faster, safer and smarter. | $1.3M / Seed / Dec 16, 2021 | |
Qualus
|
Qualus is the provider of sustainable solutions to the leather industry, has secured £1 million of financing in a round led by Irrus Investments, an Ireland based angel syndicate. Co-investors in the round include CPI Enterprises and angels from Cambridge Capital Group and Harvard Business School Alumni Angels of London. | $1.4M / Angel / Jun 01, 2021 | |
|
Cambridge GaN Devices
|
Cambridge GaN Devices develops transistors designed to bring widespread adoption of GaN technology in consumer electronics. | $9.5M / Series A / Feb 18, 2021 | |
Porotech
|
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry.The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. RachelOliver. | $1.9M / Seed / Apr 08, 2020 | |
SupaPass
|
SupaPass is an all-in-one website and app creation platform for any business to launch its own website and apps. SupaPass allows anyone to create beautiful and powerful, payment-ready, all-in-one content website and mobile apps instantly without any technical knowledge.With millions of individuals and businesses globally needing a launch-ready,affordable content driven website and app, SupaPass is an innovative white-label platform that allows clients to retain 100% of sales and full ownership of customer data at the touch of a button. It offers more cost-effective and intuitive designs to make content such as podcasts, video, audio and streaming channels more manageable, it is over 10 times faster and cheaper than custom-built solutions.With SupaPass’s technology clients are able to keep their own brand front and control how they interact with their customers. With a content layout similar to Netflix and Prime, SupaPass gives clients the tools they need to have everything in one place to grow their business online. It services a wide range of sectors and verticals including Podcasting, Fitness, and Wellbeing, TV and Film, Archives, Membership Organisations, Music, Sport, Charities, Conferences, and Consultancies.SupaPass was founded in 2011. | $618.5K / Seed / Mar 30, 2020 | |
|
SupaPass
|
SupaPass is an all-in-one website and app creation platform for any business to launch its own website and apps. SupaPass allows anyone to create beautiful and powerful, payment-ready, all-in-one content website and mobile apps instantly without any technical knowledge.With millions of individuals and businesses globally needing a launch-ready,affordable content driven website and app, SupaPass is an innovative white-label platform that allows clients to retain 100% of sales and full ownership of customer data at the touch of a button. It offers more cost-effective and intuitive designs to make content such as podcasts, video, audio and streaming channels more manageable, it is over 10 times faster and cheaper than custom-built solutions.With SupaPass’s technology clients are able to keep their own brand front and control how they interact with their customers. With a content layout similar to Netflix and Prime, SupaPass gives clients the tools they need to have everything in one place to grow their business online. It services a wide range of sectors and verticals including Podcasting, Fitness, and Wellbeing, TV and Film, Archives, Membership Organisations, Music, Sport, Charities, Conferences, and Consultancies.SupaPass was founded in 2011. | $542K / Seed / Dec 30, 2018 | |
Lightpoint Medical
|
Lightpoint Medical is an early-stage medical device company founded in 2012. The company is developing a breakthrough intraoperative imaging technology called Cerenkov Luminescence Imaging (CLI). CLI has the potential to detect cancer in real-time during surgery, and thereby reduce the likelihood of cancer recurrence and the need for reoperation. | $6.5M / Series B / Dec 06, 2018 | |
| See all 43 investments → | |||
Co-Investors
Cambridge Angels group
17 deals together
3i Group
6 deals together
Martlet Capital
6 deals together
Parkwalk Advisors
6 deals together
University of Cambridge Enterprise
6 deals together
Angel Academe
5 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Cambridge Capital Group invest in?
Cambridge Capital Group invests primarily in Software, Biotechnology and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 43 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Cambridge Capital Group's check size?
Cambridge Capital Group typically joins rounds of $548k–$1.9M at Seed and $1.3M–$9.5M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Cambridge Capital Group participates in.
How do I contact Cambridge Capital Group?
Public channels for Cambridge Capital Group include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cambridge Capital Group?
The team at Cambridge Capital Group includes Jayne Parker (Managing Director) and Struan McDougall (Founder & Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
